U.S., July 2 -- An application to own the trademark for 'EUNUVY' has been filed on Jul. 01, 2022.
Owner(s):
Sage Therapeutics, Inc.; 215 First Street, , MASSACHUSETTS
Goods and/or Services:
For: pharmaceutical preparations for the treatment of epilepsy, essential tremors, Parkinson's disease, epileptiform disorders, Huntington's disease, Alzheimer's, dementia, GABA hypofunction, and NMDA hypofunction; pharmaceutical preparations for use in the treatment of central nervous system diseases and disorders, depression, anxiety disorder, and bipolar depression
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-07-01&serialNumber=97485013
Disclaimer: Curat...